NCT02487277 2020-01-02PEGPH20, Gemicitabine and Nab-Paclitaxel for Pancreatic Ductal AdenocarcinomaUniversity of California, San FranciscoPhase 2 Terminated3 enrolled 8 charts
NCT03481920 2019-08-22A Trial of PEGPH20 in Combination With Avelumab in Chemotherapy Resistant Pancreatic CancerPH Research, S.L.Phase EARLY_PHASE1 Terminated7 enrolled